Drug exposure for PDA closure in France: a prospective, cohort-based, analysis - Archive ouverte HAL Access content directly
Journal Articles European Journal of Clinical Pharmacology Year : 2020

Drug exposure for PDA closure in France: a prospective, cohort-based, analysis

(1, 2) , (1) , (1) , (3) , (3) , (1) , (1, 2)
1
2
3

Abstract

To describe the exposure to drugs used for the treatment of patent ductus arteriosus (PDA) in a large cohort of preterm infants born before 32 weeks of gestation. METHODS: A prospective observational cohort analysis was conducted during 2 years in 28 French level 3 NICU using the same computerized order-entry system. The main outcome was "a medically treated PDA," defined as exposure to ibuprofen, indomethacin, or paracetamol prescribed with the indication of PDA closure. Secondary outcomes were as follows: time of the first treatment administration; total exposure to furosemide during hospitalization; and rate of PDA refractory to pharmacological closure. RESULTS: The study cohort consisted of 2614 infants. Among them, 474 (18.1%) received a medical treatment for PDA, with a mean postnatal age at treatment of 4.3 ± 6.6 days. The drug used as a first-line treatment was ibuprofen in 89.5% and paracetamol in 10.5%. One hundred and ninety-five infants (7.4%) had a PDA refractory to pharmacological closure. At the multivariate analysis, factors associated with PDA refractory to pharmacological closure (OR; 95% CI) were as follows: gestational age (GA) (0.81; 0.72-0.90), paracetamol as the first-line treatment (0.32; 0.15-0.68), and pharmacological treatment before 48 h of life (0.63; 0.43-0.94). 24.6% of the study cohort was exposed to furosemide (cumulative dose 6.5 ± 12.6 mg/kg). Variables significantly associated with higher cumulative doses of furosemide were lower GA and ibuprofen treatment (both p < 0.0001). CONCLUSION: Drug utilization patterns in infants with PDA vary among centers. Pharmacoepidemiology studies can provide new information on factors associated with PDA refractory to medical treatment.
Not file

Dates and versions

hal-03070829 , version 1 (16-12-2020)

Identifiers

Cite

Silvia Iacobelli, Simon Lorrain, Béatrice Gouyon, Silvia Gambacorta, Nicola Laforgia, et al.. Drug exposure for PDA closure in France: a prospective, cohort-based, analysis. European Journal of Clinical Pharmacology, 2020, 76 (12), pp.1765-1772. ⟨10.1007/s00228-020-02974-1⟩. ⟨hal-03070829⟩
36 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More